These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17482953)

  • 1. Aggressive behavior of low-grade Ta papillary urothelial bladder neoplasm in a 17-year-old patient.
    Labanaris AP; Labanaris PG; Gitsos G; Kühn R; Schott GE; Zugor V
    Urology; 2007 May; 69(5):983.e1-2. PubMed ID: 17482953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI; Tsolos C; Touloupidis S
    Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
    J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy.
    Dangle PP; Wang WP; Mayerson J; Mortazavi A; Monk P
    World J Surg Oncol; 2008 Sep; 6():103. PubMed ID: 18826578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of superficial bladder cancer.
    Dalbagni G
    Nat Clin Pract Urol; 2007 May; 4(5):254-60. PubMed ID: 17483810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
    Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
    deVere White RW; Katz MH; Steinberg GD
    J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal naevus syndrome (Solomon's syndrome) associated with bladder cancer in a 20-year-old female.
    García de Jalón A; Azúa-Romeo J; Trivez MA; Pascual D; Blas M; Rioja LA
    Scand J Urol Nephrol; 2004; 38(1):85-7. PubMed ID: 15204433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique.
    Montironi R; Cheng L; Mazzucchelli R; Scarpelli M; Kirkali Z; Montorsi F; Lopez-Beltran A
    Eur Urol; 2009 Jun; 55(6):1305-9. PubMed ID: 18995951
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Watchful waiting policy in recurrent Ta G1 bladder tumors.
    Gofrit ON; Pode D; Lazar A; Katz R; Shapiro A
    Eur Urol; 2006 Feb; 49(2):303-6; discussion 306-7. PubMed ID: 16413659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
    Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
    J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.